Annual Operating Profit
-$73.49 M
+$130.93 M+64.05%
December 31, 2023
Summary
- As of February 8, 2025, FOLD annual operating income is -$73.49 million, with the most recent change of +$130.93 million (+64.05%) on December 31, 2023.
- During the last 3 years, FOLD annual operating profit has risen by +$170.36 million (+69.86%).
- FOLD annual operating profit is now -1161.05% below its all-time high of -$5.83 million, reached on December 31, 2009.
Performance
FOLD Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$24.80 M
+$9.84 M+65.71%
September 30, 2024
Summary
- As of February 8, 2025, FOLD quarterly operating income is $24.80 million, with the most recent change of +$9.84 million (+65.71%) on September 30, 2024.
- Over the past year, FOLD quarterly operating profit has increased by +$39.83 million (+265.04%).
- FOLD quarterly operating profit is now -28.04% below its all-time high of $34.46 million, reached on December 31, 2009.
Performance
FOLD Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$14.40 M
+$39.83 M+156.63%
September 30, 2024
Summary
- As of February 8, 2025, FOLD TTM operating income is $14.40 million, with the most recent change of +$39.83 million (+156.63%) on September 30, 2024.
- Over the past year, FOLD TTM operating profit has increased by +$124.95 million (+113.03%).
- FOLD TTM operating profit is now at all-time high.
Performance
FOLD TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
FOLD Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.0% | +265.0% | +113.0% |
| 3 y3 years | +69.9% | +265.0% | +113.0% |
| 5 y5 years | +77.4% | +265.0% | +113.0% |
FOLD Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.0% | at high | +135.2% | at high | +106.0% |
| 5 y | 5-year | at high | +75.6% | at high | +128.1% | at high | +104.8% |
| alltime | all time | -1161.0% | +77.4% | -28.0% | +116.0% | at high | +103.8% |
Amicus Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $24.80 M(+65.7%) | $14.40 M(-156.6%) |
| Jun 2024 | - | $14.97 M(-169.0%) | -$25.43 M(-56.0%) |
| Mar 2024 | - | -$21.68 M(+487.1%) | -$57.78 M(-21.4%) |
| Dec 2023 | -$73.49 M(-64.0%) | -$3.69 M(-75.4%) | -$73.49 M(-33.5%) |
| Sep 2023 | - | -$15.03 M(-13.6%) | -$110.55 M(-14.2%) |
| Jun 2023 | - | -$17.39 M(-53.5%) | -$128.79 M(-25.1%) |
| Mar 2023 | - | -$37.38 M(-8.2%) | -$171.90 M(-15.9%) |
| Dec 2022 | -$204.43 M(+2.3%) | -$40.74 M(+22.5%) | -$204.43 M(-12.7%) |
| Sep 2022 | - | -$33.27 M(-45.0%) | -$234.09 M(-2.4%) |
| Jun 2022 | - | -$60.50 M(-13.5%) | -$239.93 M(+10.4%) |
| Mar 2022 | - | -$69.91 M(-0.7%) | -$217.25 M(+8.7%) |
| Dec 2021 | -$199.92 M(-18.0%) | -$70.41 M(+80.0%) | -$199.92 M(+3.1%) |
| Sep 2021 | - | -$39.11 M(+3.4%) | -$193.88 M(-6.1%) |
| Jun 2021 | - | -$37.81 M(-28.1%) | -$206.50 M(-5.8%) |
| Mar 2021 | - | -$52.58 M(-18.3%) | -$219.31 M(-10.1%) |
| Dec 2020 | -$243.85 M(-18.9%) | -$64.37 M(+24.4%) | -$243.85 M(-9.0%) |
| Sep 2020 | - | -$51.73 M(+2.2%) | -$267.86 M(-1.8%) |
| Jun 2020 | - | -$50.63 M(-34.4%) | -$272.65 M(-8.5%) |
| Mar 2020 | - | -$77.13 M(-12.7%) | -$297.97 M(-0.9%) |
| Dec 2019 | -$300.74 M(-7.6%) | -$88.38 M(+56.4%) | -$300.74 M(+6.9%) |
| Sep 2019 | - | -$56.52 M(-25.6%) | -$281.25 M(-25.9%) |
| Jun 2019 | - | -$75.95 M(-4.9%) | -$379.61 M(+8.4%) |
| Mar 2019 | - | -$79.90 M(+16.0%) | -$350.29 M(+7.6%) |
| Dec 2018 | -$325.48 M(+54.3%) | -$68.88 M(-55.5%) | -$325.48 M(+1.7%) |
| Sep 2018 | - | -$154.88 M(+232.1%) | -$319.97 M(+46.0%) |
| Jun 2018 | - | -$46.63 M(-15.3%) | -$219.15 M(+0.3%) |
| Mar 2018 | - | -$55.08 M(-13.1%) | -$218.53 M(+3.6%) |
| Dec 2017 | -$210.88 M(+20.5%) | -$63.38 M(+17.2%) | -$210.88 M(+7.9%) |
| Sep 2017 | - | -$54.05 M(+17.5%) | -$195.38 M(+2.6%) |
| Jun 2017 | - | -$46.01 M(-3.0%) | -$190.36 M(+4.2%) |
| Mar 2017 | - | -$47.44 M(-0.9%) | -$182.70 M(+4.4%) |
| Dec 2016 | -$175.06 M(+38.9%) | -$47.88 M(-2.4%) | -$175.06 M(+4.5%) |
| Sep 2016 | - | -$49.04 M(+27.9%) | -$167.58 M(+7.9%) |
| Jun 2016 | - | -$38.35 M(-3.6%) | -$155.28 M(+8.7%) |
| Mar 2016 | - | -$39.80 M(-1.5%) | -$142.80 M(+13.3%) |
| Dec 2015 | -$126.05 M | -$40.39 M(+10.0%) | -$126.05 M(+17.6%) |
| Sep 2015 | - | -$36.74 M(+42.0%) | -$107.14 M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$25.86 M(+12.2%) | -$87.80 M(+14.6%) |
| Mar 2015 | - | -$23.05 M(+7.3%) | -$76.59 M(+11.5%) |
| Dec 2014 | -$68.66 M(+10.4%) | -$21.49 M(+23.5%) | -$68.66 M(+12.6%) |
| Sep 2014 | - | -$17.40 M(+18.8%) | -$60.98 M(+3.9%) |
| Jun 2014 | - | -$14.65 M(-3.1%) | -$58.71 M(-2.3%) |
| Mar 2014 | - | -$15.12 M(+9.6%) | -$60.07 M(-3.4%) |
| Dec 2013 | -$62.19 M(+17.5%) | -$13.80 M(-8.8%) | -$62.19 M(-3.3%) |
| Sep 2013 | - | -$15.13 M(-5.4%) | -$64.31 M(-2.7%) |
| Jun 2013 | - | -$16.00 M(-7.2%) | -$66.09 M(+11.2%) |
| Mar 2013 | - | -$17.25 M(+8.3%) | -$59.44 M(+12.3%) |
| Dec 2012 | -$52.93 M(+4.0%) | -$15.92 M(-5.9%) | -$52.93 M(+5.8%) |
| Sep 2012 | - | -$16.92 M(+81.0%) | -$50.04 M(+8.2%) |
| Jun 2012 | - | -$9.35 M(-13.0%) | -$46.26 M(-10.4%) |
| Mar 2012 | - | -$10.74 M(-17.5%) | -$51.63 M(+1.5%) |
| Dec 2011 | -$50.89 M(-8.9%) | -$13.03 M(-0.8%) | -$50.89 M(-6.4%) |
| Sep 2011 | - | -$13.13 M(-10.8%) | -$54.39 M(-0.2%) |
| Jun 2011 | - | -$14.72 M(+47.3%) | -$54.52 M(+3.9%) |
| Mar 2011 | - | -$10.00 M(-39.5%) | -$52.49 M(-6.0%) |
| Dec 2010 | -$55.84 M(+858.1%) | -$16.54 M(+24.7%) | -$55.84 M(+1054.4%) |
| Sep 2010 | - | -$13.27 M(+4.6%) | -$4.84 M(-4.1%) |
| Jun 2010 | - | -$12.69 M(-5.0%) | -$5.05 M(-18.8%) |
| Mar 2010 | - | -$13.35 M(-138.7%) | -$6.21 M(+6.5%) |
| Dec 2009 | -$5.83 M(-86.7%) | $34.46 M(-355.8%) | -$5.83 M(-89.4%) |
| Sep 2009 | - | -$13.47 M(-2.7%) | -$55.17 M(+8.2%) |
| Jun 2009 | - | -$13.85 M(+6.8%) | -$51.00 M(+7.1%) |
| Mar 2009 | - | -$12.97 M(-12.8%) | -$47.64 M(+8.4%) |
| Dec 2008 | -$43.96 M(-4.0%) | -$14.88 M(+60.0%) | -$43.96 M(+3.3%) |
| Sep 2008 | - | -$9.30 M(-11.4%) | -$42.56 M(-5.6%) |
| Jun 2008 | - | -$10.49 M(+13.0%) | -$45.07 M(+0.5%) |
| Mar 2008 | - | -$9.29 M(-31.1%) | -$44.86 M(-2.1%) |
| Dec 2007 | -$45.80 M(-2.2%) | -$13.48 M(+14.2%) | -$45.80 M(+41.7%) |
| Sep 2007 | - | -$11.81 M(+14.8%) | -$32.32 M(+57.5%) |
| Jun 2007 | - | -$10.28 M(+0.5%) | -$20.52 M(+100.5%) |
| Mar 2007 | - | -$10.23 M | -$10.23 M |
| Dec 2006 | -$46.86 M(+124.9%) | - | - |
| Dec 2005 | -$20.83 M(+215.6%) | - | - |
| Dec 2003 | -$6.60 M | - | - |
FAQ
- What is Amicus Therapeutics annual operating income?
- What is the all time high annual operating profit for Amicus Therapeutics?
- What is Amicus Therapeutics annual operating profit year-on-year change?
- What is Amicus Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly operating profit year-on-year change?
- What is Amicus Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Amicus Therapeutics?
- What is Amicus Therapeutics TTM operating profit year-on-year change?
What is Amicus Therapeutics annual operating income?
The current annual operating profit of FOLD is -$73.49 M
What is the all time high annual operating profit for Amicus Therapeutics?
Amicus Therapeutics all-time high annual operating income is -$5.83 M
What is Amicus Therapeutics annual operating profit year-on-year change?
Over the past year, FOLD annual operating income has changed by +$130.93 M (+64.05%)
What is Amicus Therapeutics quarterly operating income?
The current quarterly operating profit of FOLD is $24.80 M
What is the all time high quarterly operating profit for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly operating income is $34.46 M
What is Amicus Therapeutics quarterly operating profit year-on-year change?
Over the past year, FOLD quarterly operating income has changed by +$39.83 M (+265.04%)
What is Amicus Therapeutics TTM operating income?
The current TTM operating profit of FOLD is $14.40 M
What is the all time high TTM operating profit for Amicus Therapeutics?
Amicus Therapeutics all-time high TTM operating income is $14.40 M
What is Amicus Therapeutics TTM operating profit year-on-year change?
Over the past year, FOLD TTM operating income has changed by +$124.95 M (+113.03%)